NCT02141815View on ClinicalTrials.gov

AXOS and Microbial Metabolites in CKD

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Arabinoxylan-oligosaccharides

DIETARY_SUPPLEMENT

Maltodextrine

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02141815 - AXOS and Microbial Metabolites in CKD | Biotech Hunter | Biotech Hunter